Notably, the antifibrotic drug fluorofenidone (AKF-PD) inhibits HSCs autophagy via the TGF-β1/Smad pathway, thereby attenuating liver fibrosis (82). This evidence concerns the gene TGFB1 and Hepatic fibrosis.